Antidiabetic agent could smother pancreatic cancer stem cells Metformin, commonly used for diabetes, was found to shut down metabolism in pancreatic cancer stem cells, which can spread cancer around the body.…
Placebos: more than meets the eye Often dismissed as fakes, placebos seem to work on the same brain pathways targeted by ‘real’ treatments and involve a complex network of genes.…
Genetics accounts for 50% of the risk of a common testicular cancer Environmental factors are strongly implicated in the development of testicular cancer, but up to 50% of the risk is attributable to genetics, suggests a new analysis of Swedish population data.…
Pharmacists must prepare for changing NHS, RPS conference hears The pharmacy profession will need to adapt its clinical practice within a changing NHS as the health service adjusts to meet demand, attendees at the Royal Pharmaceutical Society’s annual conference heard.…
Asthma therapies get personal A new crop of biologic drugs promises to usher asthma treatment into the realm of personalised medicine.…
FDA approves drug for genetic condition that affects 20 patients worldwide The US Food and Drug Administration has approved uridine triacetate (Xuriden) for the treatment of orotic aciduria – a rare genetic hereditary metabolic disorder that affects just 20 patients worldwide. …
Local anaesthetics can affect tooth development in children Local anaesthetics routinely given to children undergoing dental treatment may affect tooth cell growth and development.…
Scientists find another link between aspirin and cancer treatment A study by UK researchers has found a possible explanation for a reported link between aspirin and a reduced risk of cancer.…
Penicillin allergy: identification and management How to assess patients for true penicillin allergy and make appropriate treatment choices.…
Young children receiving new meningitis vaccine can benefit from paracetamol The meningococcal group B (MenB) Bexsero vaccine will be added to the NHS childhood immunisation programme in England from 1 September 2015.…